Clinical Trials List
Protocol NumberRTG115860
2011-12-01 - 2011-03-30
Phase I
Terminated1
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
16 participants
